Home › Depression › NCT07174557

Remote Evaluation and Alerting for Collaborative Health (REACH) in Depression

Beyond the Clinic: Enhancing Depression Surveillance With a Digital Biomarker

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Adult patients (18 years or older)
* Treated for depression within Dartmouth Health collaborative care model (CoCM) sites who are discharged from CoCM without depression (PHQ-9 \< 10)
* Have access to and ability to use a smartphone (Android version ≥ 6 or iOS version ≥ 11).

Exclusion Criteria:

* Identified as high risk due to active suicidality, psychosis, or bipolar disorder - Discharged from CoCM with ongoing depressive symptoms (PhQ-9 \> 10

About the study

Researchers hope to see if the data smartphones collect continuously can be used to predict if patient's depression symptoms will return. They will do this by collecting data from patient's smartphones and comparing it to their depression symptoms. If this method is successful, researchers could develop a smartphone application to help healthcare providers better monitor patient's depression and intervene earlier if symptoms return.

What is being tested

• MoodTriggers Application (other)

Sponsor: Dartmouth-Hitchcock Medical Center · Participants: 320 · Started: May 20, 2026

Contact the study team

• Nicholas C Jacobson, PhD · Phone: (603) 646-7037

Official record on ClinicalTrials.gov — NCT07174557

Locations in the U.S.

Conditions

• Depression
• Major Depressive Disorder

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.